Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease
- PMID: 25479760
- DOI: 10.1016/j.jaut.2014.11.001
Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease
Abstract
Improved clinical findings of inflammatory bowel disease (IBD) upon treatment with helminthes and their ova were proven in animal models of IBD and in human clinical studies. The immunomodulatory properties of several helminthes were attributed to the phosphorylcholine (PC) molecule. We assessed the therapeutic potential of tuftsin-PC conjugate (TPC) to attenuate murine colitis. Colitis was induced by Dextransulfate-Sodium-Salt (DSS) in drinking water. TPC was given by daily oral ingestion (50 μg/0.1 ml/mouse or PBS) starting at day -2. Disease activity index (DAI) score was followed daily and histology of the colon was performed by H&E staining. Analysis of the cytokines profile in distal colon lysates was performed by immunoblot. Treatment of DSS induced colitis with TPC prevented the severity of colitis, including a reduction in the DAI score, less shortening of the colon and less inflammatory activity in histology. The immunoblot showed that the colitis preventive activity of TPC was associated with downregulation of colon pro-inflammatory IL-1β, TNFα and IL-17 cytokines expression, and enhancement of anti-inflammatory IL-10 cytokine expression. In the current study, we demonstrated that TPC treatment can prevent significantly experimental colitis induction in naïve mice. We propose the TPC as a novel potential small synthetic molecule to treat colitis.
Keywords: Colitis; Helminthes; Inflammatory bowel disease; Phosphorylcholine; Tuftsin; Worms.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.J Autoimmun. 2015 May;59:1-7. doi: 10.1016/j.jaut.2015.03.001. Epub 2015 Apr 10. J Autoimmun. 2015. PMID: 25864802
-
Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.Pharmacol Res. 2012 Jul;66(1):66-79. doi: 10.1016/j.phrs.2012.03.013. Epub 2012 Mar 28. Pharmacol Res. 2012. PMID: 22475725
-
Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis.J Mol Med (Berl). 2018 Aug;96(8):831-843. doi: 10.1007/s00109-018-1658-1. Epub 2018 Jun 20. J Mol Med (Berl). 2018. PMID: 29967942
-
Tuftsin phosphorylcholine-a novel compound harnessing helminths to fight autoimmunity.Immunol Res. 2018 Dec;66(6):637-641. doi: 10.1007/s12026-018-9051-2. Immunol Res. 2018. PMID: 30554380 Review.
-
Helminth-Related Tuftsin-Phosphorylcholine Compound and its Interplay with Autoimmune Diseases.Isr Med Assoc J. 2019 Mar;21(3):158-162. Isr Med Assoc J. 2019. PMID: 30905098 Review.
Cited by
-
Probiotic Mixture Protects Dextran Sulfate Sodium-Induced Colitis by Altering Tight Junction Protein Expressions and Increasing Tregs.Mediators Inflamm. 2018 Apr 15;2018:9416391. doi: 10.1155/2018/9416391. eCollection 2018. Mediators Inflamm. 2018. PMID: 29849501 Free PMC article.
-
Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease.Int J Mol Sci. 2020 May 31;21(11):3956. doi: 10.3390/ijms21113956. Int J Mol Sci. 2020. PMID: 32486445 Free PMC article. Review.
-
Autoimmunity in 2015.Clin Rev Allergy Immunol. 2016 Aug;51(1):110-9. doi: 10.1007/s12016-016-8576-1. Clin Rev Allergy Immunol. 2016. PMID: 27422713 Review.
-
Immunomodulation of Murine Chronic DSS-Induced Colitis by Tuftsin-Phosphorylcholine.J Clin Med. 2019 Dec 26;9(1):65. doi: 10.3390/jcm9010065. J Clin Med. 2019. PMID: 31888063 Free PMC article.
-
Polyene Phosphatidylcholine Interacting with TLR-2 Prevents the Synovial Inflammation via Inactivation of MAPK and NF-κB Pathways.Inflammation. 2022 Aug;45(4):1507-1519. doi: 10.1007/s10753-022-01633-0. Epub 2022 Feb 2. Inflammation. 2022. PMID: 35107766
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources